Organising the language of Alzheimer’s disease in light of biomarkers

Organising the language of Alzheimer’s disease in light of biomarkers, The Lancet Neurology, Volume 9, Issue 11, Pages 1044 – 1045, November 2010 Schneider Abstract: Criteria for Alzheimer’s disease dementia have served clinicians remarkably well for the past 25 years despite the fact that they predate knowledge of biomarkers, quantitative neuroimaging, other dementias of late [...]

Revising the definition of Alzheimer’s disease: a new lexicon

Revising the definition of Alzheimer’s disease: a new lexicon, The Lancet Neurology, Volume 9, Issue 11, Pages 1118 – 1127, November 2010 Prof Bruno Dubois MD et al. Abstract: Alzheimer’s disease (AD) is classically defined as a dual clinicopathological entity. The recent advances in use of reliable biomarkers of AD that provide in-vivo evidence of [...]

Risk Assessment – Suicide and schizophrenia: a systematic review of rates and risk factors

Suicide and schizophrenia: a systematic review of rates and risk factors, Journal of Psychopharmacology,  2010 November; 24(11_supplement): 81–90 Kahyee Hor and Mark Taylor Abstract: Risk assessment is a core skill in psychiatry. Risk prediction for suicide in schizophrenia is known to be complex. We undertook a systematic review of all original studies concerning suicide in schizophrenia [...]

The Equality Act 2010: employment implications for the NHS – October 2010

The Equality Act 2010: employment implications for the NHS – October 2010  Click on the title to again access to the full-text of this briefing Abstract: This briefing aims to give the latest position and understanding about the Equality Act from a human resources perspective. It also aims to help NHS organisations to ensure that [...]